Aspiration pneumonia primary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Aspiration pneumonia}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no available v...")
 
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Aspiration pneumonia}}
{{Aspiration pneumonia}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SSH}}


==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
Effective measures for the primary prevention of aspiration pneumonia include [[Diet (nutrition)|dietary]] habit changes, maintaining [[oral hygiene]], postural maneuvers, and [[Medication|medications]] such as [[H2 antagonist|H2 antagonists]], [[metoclopramide]], [[mosapride]], [[amantadine]], or [[cilostazol]].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
*There are no established measures for the primary prevention of [disease name].
*Effective measures for the primary prevention of aspiration pneumonia include:<ref name="pmid18179994">{{cite journal |vauthors=El Solh AA, Saliba R |title=Pharmacologic prevention of aspiration pneumonia: a systematic review |journal=Am J Geriatr Pharmacother |volume=5 |issue=4 |pages=352–62 |date=December 2007 |pmid=18179994 |doi=10.1016/j.amjopharm.2007.12.005 |url=}}</ref><ref name="pmid18261707">{{cite journal |vauthors=Sarin J, Balasubramaniam R, Corcoran AM, Laudenbach JM, Stoopler ET |title=Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions |journal=J Am Med Dir Assoc |volume=9 |issue=2 |pages=128–35 |date=February 2008 |pmid=18261707 |doi=10.1016/j.jamda.2007.10.003 |url=}}</ref><ref name="pmid23238778">{{cite journal |vauthors=Takatori K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Yoneda S, Adachi K, Amano Y, Kinoshita Y |title=Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding |journal=J. Gastroenterol. |volume=48 |issue=10 |pages=1105–10 |date=October 2013 |pmid=23238778 |doi=10.1007/s00535-012-0725-6 |url=}}</ref>
*There are no available vaccines against [disease name].
**Bed positioning
OR
**[[Diet (nutrition)|Dietary]] habit changes such as:
*Effective measures for the primary prevention of [disease name] include:
***Eating small meals at a slow pace and consistent
**[Measure1]
***Elevated position at least 1 to 2 hours after meals
**[Measure2]
***Elemental diets in bedridden [[PEG gastroscopy|PEG]] patients
**[Measure3]
**Good [[oral hygiene]] such as:
OR
***Professional cleaning of the oral cavity weekly
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
***Tooth brushing after each meal
**[Strategy 1]
***Cleaning [[dentures]] daily
**[Strategy 2]
***Gargling of [[disinfectant]] solution
**[Strategy 3]
**Postural maneuvers and [[swallowing]] training to improve [[swallowing]] difficulties
 
**Checking [[Feeding tube|feeding tubes]] regularly to prevent displacement
 
**Administrating postpyloric [[feeding]] than [[Feeding tube|gastric feeding]]
**[[Medication|Medications]] such as:
***[[H2 antagonist|Histamine-2 receptor antagonists]]
***[[Metoclopramide]] 
***[[Mosapride]
***[[Amantadine]] 
***[[Cilostazol]] 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 16:39, 4 April 2018

Aspiration pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aspiration Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Aspiration pneumonia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aspiration pneumonia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aspiration pneumonia primary prevention

CDC onAspiration pneumonia primary prevention

Aspiration pneumonia primary prevention in the news

Blogs on Aspiration pneumonia primary prevention

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Aspiration pneumonia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Effective measures for the primary prevention of aspiration pneumonia include dietary habit changes, maintaining oral hygiene, postural maneuvers, and medications such as H2 antagonists, metoclopramide, mosapride, amantadine, or cilostazol.

Primary Prevention

References

  1. El Solh AA, Saliba R (December 2007). "Pharmacologic prevention of aspiration pneumonia: a systematic review". Am J Geriatr Pharmacother. 5 (4): 352–62. doi:10.1016/j.amjopharm.2007.12.005. PMID 18179994.
  2. Sarin J, Balasubramaniam R, Corcoran AM, Laudenbach JM, Stoopler ET (February 2008). "Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions". J Am Med Dir Assoc. 9 (2): 128–35. doi:10.1016/j.jamda.2007.10.003. PMID 18261707.
  3. Takatori K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Yoneda S, Adachi K, Amano Y, Kinoshita Y (October 2013). "Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding". J. Gastroenterol. 48 (10): 1105–10. doi:10.1007/s00535-012-0725-6. PMID 23238778.

Template:WH Template:WS